Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy invivo

Biomaterials

Volumn 34, Issue 34, 2013, Pages 8798-8807

  Chen, Wei Hai ^a   Xu, Xiao Ding ^a   Jia, Hui Zhen ^a   Lei, Qi ^a   Luo, Guo Feng ^a   Cheng, Si Xue ^a   Zhuo, Ren Xi ^a   Zhang, Xian Zheng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cancer imaging; Dual intelligent; Gold nanoparticle; Therapeutic nanomedicine

Indexed keywords

CANCER IMAGING; DRUG RELEASE PROPERTIES; DUAL-INTELLIGENT; FUNCTIONALIZED GOLD NANOPARTICLES; GOLD NANOPARTICLES; PEPTIDE SUBSTRATES; THERAPEUTIC SYSTEMS; TUMOR MICROENVIRONMENT;

ENZYME ACTIVITY; GOLD; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES;

TUMORS;

DOXORUBICIN; GELATINASE A; GLUTATHIONE; GOLD NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NANOMEDICINE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TUMOR MICROENVIRONMENT;

MUS;

CANCER IMAGING; DUAL-INTELLIGENT; GOLD NANOPARTICLE; THERAPEUTIC NANOMEDICINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; GOLD; HT29 CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; NANOMEDICINE; NEOPLASMS;

EID: 84882815878     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.084     Document Type: Article

References (45)

1. Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat Rev Cancer 2006, 6:583-592.
2. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
3. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
4. Mukerjee A., Ranjan A.P., Vishwanatha J.K. Combinatorial nanoparticles for cancer diagnosis and therapy. Curr Med Chem 2012, 19:3714-3721.
5. Saha K., Agasti S.S., Kim C., Li X., Rotello V.M. Gold nanoparticles in chemical and biological sensing. Chem Rev 2012, 112:2739-2779.
6. Rana S., Bajaj A., Mout R., Rotello V.M. Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev 2012, 64:200-216.
7. Giljohann D.A., Seferos D.S., Daniel W.L., Massich M.D., Patel P.C., Mirkin C.A. Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 2010, 49:3280-3294.
8. Kudgus R.A., Bhattacharya R., Mukherjee P. Cancer nanotechnology: emerging role of gold nanoconjugates. Anticancer Agents Med Chem 2011, 11:965-973.
9. Boisselier E., Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38:1759-1782.
10. Gibson J.D., Khanal B.P., Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. JAm Chem Soc 2007, 129:11653-11661.
11. Wang F., Wang Y.C., Dou S., Xiong M.H., Sun T.M., Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 2011, 5:3679-3692.
12. Agasti S.S., Chompoosor A., You C.C., Ghosh P., Kim C.K., Rotello V.M. Photoregulated release of caged anticancer drugs from gold nanoparticles. JAm Chem Soc 2009, 131:5728-5729.
13. Kim C., Agasti S.S., Zhu Z., Isaacs L., Rotello V.M. Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nat Chem 2010, 2:962-966.
14. Hong R., Han G., Fernández J.M., Kim B.J., Forbes N.S., Rotello V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. JAm Chem Soc 2006, 128:1078-1079.
15. Kim B., Han G., Toley B.J., Kim C.K., Rotello V.M., Forbes N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 2010, 5:465-472.
16. Service R.F. Materials and biology. Nanotechnology takes aim at cancer. Science 2005, 310:1132-1134.
17. Cuenca A.G., Jiang H., Hochwald S.N., Delano M., Cance W.G., Grobmyer S.R. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006, 107:459-466.
18. Shi D., Bedford N.M., Cho H.S. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics. Small 2011, 7:2549-2567.
19. Farokhzad O.C., Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006, 58:1456-1459.
20. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
21. Lee S., Cha E.J., Park K., Lee S.Y., Hong J.K., Sun I.C., et al. Anear-infrared-fluorescence-quenched gold-nanoparticle imaging probe for invivo drug screening and protease activity determination. Angew Chem Int Ed Engl 2008, 47:2804-2807.
22. Jiang T., Olson E.S., Nguyen Q.T., Roy M., Jennings P.A., Tsien R.Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 2004, 101:17867-17872.
23. Vihinen P., Ala-aho R., Kähäri V.M. Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 2005, 5:203-220.
24. Aureli L., Gioia M., Cerbara I., Monaco S., Fasciglione G.F., Marini S., et al. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases. Curr Med Chem 2008, 15:2192-2222.
25. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
26. Guarise C., Pasquato L., De Filippis V., Scrimin P. Gold nanoparticles-based protease assay. Proc Natl Acad Sci U S A 2006, 103:3978-3982.
27. Cheng Y., C Samia A., Meyers J.D., Panagopoulos I., Fei B., Burda C. Highly efficient drug delivery with gold nanoparticle vectors for invivo photodynamic therapy of cancer. JAm Chem Soc 2008, 130:10643-10647.
28. Karakoti A.S., Das S., Thevuthasan S., Seal S. PEGylated inorganic nanoparticles. Angew Chem Int Ed Engl 2011, 50:1980-1994.
29. Sapsford K.E., Berti L., Medintz I.L. Materials for fluorescence resonance energy transfer analysis: beyond traditional donor-acceptor combinations. Angew Chem Int Ed Engl 2006, 45:4562-4589.
30. Darbha G.K., Ray A., Ray P.C. Gold nanoparticle-based miniaturized nanomaterial surface energy transfer probe for rapid and ultrasensitive detection of mercury in soil, water, and fish. ACS Nano 2007, 1:208-214.
31. Mansour A.M., Drevs J., Esser N., Hamada F.M., Badary O.A., Unger C., et al. Anew approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2. Cancer Res 2003, 63:4062-4066.
32. Turkevich J., Stevenson P.C., Hillier J. Astudy of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951, 11:55-75.
33. Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat Phys Sci 1973, 241:20-22.
34. Wang H.Y., Yi W.J., Qin S.Y., Li C., Zhuo R.X., Zhang X.Z. Tyroserleutide-based gene vector for suppressing VEGF expression in cancer therapy. Biomaterials 2012, 33:8685-8694.
35. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. JCell Biol 1992, 119:493-501.
36. Olson E.S., Jiang T., Aguilera T.A., Nguyen Q.T., Ellies L.G., Scadeng M., et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for invivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A 2010, 107:4311-4316.
37. Zhang X.X., Eden H.S., Chen X. Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. JControl Release 2012, 159:2-13.
38. Kogan M.J., Bastus N.G., Amigo R., Grillo-Bosch D., Araya E., Turiel A., et al. Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett 2006, 6:110-115.
39. Bastús N.G., Sánchez-Tilló E., Pujals S., Farrera C., López C., Giralt E., et al. Homogeneous conjugation of peptides onto gold nanoparticles enhances macrophage response. ACS Nano 2009, 3:1335-1344.
40. Sun I.C., Eun D.K., Koo H., Ko C.Y., Kim H.S., Yi D.K., et al. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew Chem Int Ed Engl 2011, 50:9348-9351.
41. Zhang X., Chibli H., Mielke R., Nadeau J. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells. Bioconjug Chem 2011, 22:235-243.
42. Kalaria D.R., Sharma G., Beniwal V., Ravi Kumar M.N. Design of biodegradable nanoparticles for oral delivery of doxorubicin: invivo pharmacokinetics and toxicity studies in rats. Pharm Res 2009, 26:492-501.
43. Gokcimen A., Cim A., Tola H.T., Bayram D., Kocak A., Ozgüner F., et al. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity. Hum Exp Toxicol 2007, 26:519-525.
44. Gokcimen A., Cim A., Tola H.T., Bayram D., Kocak A., Ozgüner F., et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 2011, 5:4131-4144.
45. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004, 56:185-229.